Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Market Cap	1.45B -45.6%
Revenue (ttm)	2.73B -6.7%
Net Income	14.17M -94.3%
EPS	0.26 -94.3%
Shares Out	55.21M
PE Ratio	100.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,628
Open	24.95
Previous Close	24.97
Day's Range	24.95 - 26.21
52-Week Range	15.20 - 63.90
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Balaxi Pharmaceuticals

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BALAXI

Financial Performance

In fiscal year 2026, Balaxi Pharmaceuticals's revenue was 2.73 billion, a decrease of -6.69% compared to the previous year's 2.93 billion. Earnings were 14.17 million, a decrease of -94.35%.